Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015
December 28, 2017
Aptinyx to Present at 36th Annual J.P. Morgan Healthcare Conference
Download PDF format download (opens in new window)
December 18, 2017
Aptinyx Raises $70 Million in Series B Financing to Advance Growing Pipeline through Clinical Studies in Neurologic Disorders
Download PDF format download (opens in new window)
December 07, 2017
Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer
Download PDF format download (opens in new window)
December 07, 2017
Aptinyx Granted Fast Track Designation, Initiates Phase 1 for Second Clinical Candidate, NYX-783, in Post-Traumatic Stress Disorder
Download PDF format download (opens in new window)
November 14, 2017
Aptinyx to Present Preclinical Data for NMDA Receptor Modulators in Neurologic Disorders at Neuroscience 2017
Download PDF format download (opens in new window)
September 21, 2017
Aptinyx to Present at Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences
Download PDF format download (opens in new window)
August 01, 2017
Aptinyx Initiates Phase 2 Clinical Studies Evaluating NYX-2925 in Two Chronic Pain Conditions
Download PDF format download (opens in new window)
June 14, 2017
Aptinyx to Present Data for NYX-2925 at the 6th International Congress on Neuropathic Pain
Download PDF format download (opens in new window)
May 17, 2017
Aptinyx to Present NYX-2925 Research at American Pain Society Annual Scientific Meeting
Download PDF format download (opens in new window)
February 21, 2017
Aptinyx Chief Scientific Officer Joseph Moskal, Ph.D. Named Fellow by National Academy of Inventors and the American Institute for Medical and Biological Engineering
Download PDF format download (opens in new window)